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Muscle velocity recovery cycles: comparison between surface and needle recordings  
 
Abstract  
 
Introduction: Recording of muscle velocity recovery cycles (MVRCs) has been developed as 
a technique to investigate the pathophysiology of muscle diseases. MVRCs have been 
measured by direct muscle stimulation and concentric EMG needle recording.  This study was 
undertaken to determine if recordings can be made with surface electrodes. 
Methods: MVRCs with 1 and 2 conditioning stimuli were recorded simultaneously with 
concentric needle and surface electrodes from the brachioradialis muscle in 12 healthy 
volunteers. Muscle relative refractory period, early and late supernormality, and extra late 
supernormality were compared between the recording techniques. 
Results: Surface recordings were possible in all subjects. The multi-fiber action potentials 
recorded with surface electrodes were smaller than those recorded with needles, but there was 
no significant difference between any of their MVRC properties .  
Discussion: MVRCs can be recorded with surface electrodes in healthy subjects. The use of 
surface electrodes may facilitate the technique of recording MVRCs. 
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Abbreviations 
MAP = muscle action potential 
ESN = early supernormality  
ISI = inter-stimulus interval  
LSN = late supernormality  
MRRP = muscle relative refractory period  
MVRC = muscle velocity recovery cycles  
SEM = standard error of the mean 
XLSN = extra late supernormality  
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Introduction 
The technique of recording muscle velocity recovery cycles (MVRCs) is based on the 
principle that an evoked muscle action potential is followed by early and late depolarizing 
afterpotentials1,2.  Both influence the propagation velocity of a consecutively evoked muscle 
action potential as a function of inter-stimulus interval (ISI). By recording MVRCs the 
following parameters can be assessed: (i) muscle relative refractory period (MRRP), (ii) early 
supernormality (ESN, the maximal increase of conduction velocity due to the early 
afterpotential at about 8 ms ISI), (iii) late supernormality (LSN, the increase of conduction 
velocity at an ISI of about 100 ms related to late afterpotential), and (iv) extra late 
supernormality (XLSN, augmentation of LSN by additional conditioning stimulus)2,3.  
In previous studies, MVRC recordings have been used to demonstrate distinct changes of 
muscle membrane properties in vivo. The method has been shown to have a high 
repeatability4, no investigator dependency5, and to be applicable to different muscles5. In 
disease, the technique has demonstrated reversible ischemic membrane depolarization in 
trapezius muscles in patients with postural hypotension during standing6, hyperkalemic 
membrane depolarization in renal failure7, membrane depolarization or sodium channel 
inactivation in critical illness myopathy8 and in the very early phase of septic myopathy9, and 
membrane depolarization due to inward rectifier dysfunction in Andersen-Tawil syndrome10.  
In myotonia congenita and the myotonic dystrophies characteristic alterations due to chloride 
channel dysfunction could be demonstrated11.   
For measurement of MVRCs direct muscle stimulation with a monopolar needle electrode is 
used to excite a column of muscle fibers. To record the multi-fiber action potentials, a 
concentric EMG electrode is inserted in the muscle and placed in the vicinity of the activated 
fibers2. Placement of this recording needle can sometimes be difficult and time consuming. 
The aim of this study was to test whether surface electrode recordings can substitute for 
concentric EMG needle recordings, which might facilitate recordings. 
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Materials and Methods 
Twelve healthy subjects (5 women and 7 men; ages 23–27 years, mean 23.5years) 
participated in this study. Approval was obtained from the local ethics committee (Kantonale 
Ethikkommission, Bern, Switzerland) and conformed to the Declaration of Helsinki. All 
participants provided written informed consent.  
 
Stimulation 
Stimulation was performed as described earlier in detail2,3. In brief, subjects rested 
comfortably on a bed in a warm room. An insulated monopolar needle electrode (TECA, 
Viasys Healthcare, Madison, Wisconsin, USA) served as cathode and was inserted 
perpendicularly into the brachioradialis muscle of the non-dominant arm to a depth of about 1 
to 1.5 cm. The insertion site was about 25% of the distance from the lateral epicondyle of the 
humerus to the styloid process of the radius (Figure 1). A non-polarizable, self-adhesive 
surface electrode (Red Dot, 3M Health Care, D-46325 Borken, Germany) served as anode and 
was placed on the skin just distal to the cathode. An isolated constant-current stimulator (DS7, 
Digitimer Ltd., Welwyn Garden City, Hertfordshire, UK) was used for stimulation.  Stimulus 
duration was set at 0.05ms. 
 
Recording 
Two recording techniques were used simultaneously: (i) concentric EMG needle electrode 
and (ii) surface electrode recordings. Concentric EMG needle electrode recordings were 
performed as described earlier2,3. A concentric 30G EMG electrode (Medtronic, Skovlunde, 
Denmark) was inserted slightly oblique into the brachioradialis muscle about 20 to 25 mm 
proximal to the cathode. Small position changes were made until a stable monophasic 
response could be recorded with stimulus intensity of less than 6 mA (Figure 1). After 
positioning of the needle EMG electrode, surface electrodes were taped on the skin (diameter 
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0.8cm, Medtronic, Skovlunde, Denmark). The active electrode was placed on the skin just 
above the tip of the concentric EMG needle electrode. Two anodes were placed adjacent 
proximal and distal to the cathode. A surface electrode served as ground and was taped on the 
dorsum of the hand. Signals were amplified (gain 1000, bandwidth 1.6 Hz to 2 kHz) and 
digitized (National Instruments NI DAQCARD-6062E, National Instruments Europe Corp., 
Debrecen, Hungary) using a sampling rate of 20 kHz. Stimulation and recording were 
controlled by QTRAC software (written by H. Bostock, copyright Institute of Neurology, 
London, UK), using the menu-driven recording protocol 1200RCM2B.QRP.   
 
Stimulation protocol 
Multi-fiber MVRCs with single and paired conditioning stimuli (10 ms apart) were recorded 
as described earlier2,3. The test stimuli were delivered every 2 seconds.  The interval between 
single or paired conditioning stimulus and the test stimulus was decreased in 34 steps from 
1000 ms to 2 ms in an approximately geometric series 
 
Data analysis and statistics 
Data analysis was performed using the QTRAC software as described earlier in detail3.  The 
waveforms were transformed with forward-reverse digital filters (500 Hz high pass, 100 Hz 
low pass) to provide baseline stabilization and smoothing without time displacement3.  For 
both recording techniques the following measurements were made:  
1) amplitude of the muscle action potential (MAP);  
2) from recordings with 1 conditioning stimulus:  
a) MRRP (interpolated ISI at which velocity first reached its unconditioned value)  
b) ESN (peak percentage reduction in latency at ISIs shorter than 15 ms)  
c) Time to peak ESN (ISI at which reduction in latency was maximal) 
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d) LSN  (peak percentage reduction in latency at ISIs longer than 50 ms and shorter 
than 150 ms) 
e) Residual supernormality at an ISI of 950 ms 
3) from recordings with 2 conditioning stimuli:  
a) XLSN (peak percentage increase in velocity at ISIs longer than 50 ms and shorter 
than 150 ms due to a second conditioning stimulus) 
Statistical computations were performed by the QTRAC data analysis software. Parameters of 
needle and surface recordings were compared using the Student paired t-test. Data are 
presented as mean ± standard error of the mean (SEM). 
 
 
Results 
All subjects tolerated the examination well, and needle and surface MAPs of good quality 
could be recorded from all subjects. Figure 2 shows original multi-fiber MAPs from a single 
subject recorded simultaneously with surface and needle electrodes. Figure 3 displays the 
averaged MVRC latency changes of all 12 subjects for both recording techniques, for 
recordings with 1 conditioning stimulus and also the differences in latency change between 
recordings with 1 and 2 conditioning stimuli. Means and standard errors for peak amplitude, 
peak variability, and the MVRC measures for the 2 recording methods are compared in Table 
1. For all measurements no statistical difference was found between recordings with surface 
and needle electrodes, except that the surface action potentials were on average less than half 
the size of those recorded with needles. Figure 4 shows the individual values for both 
recording techniques for MRRP, ESN, time to peak ESN, and LSN.  Table 1 also shows the 
correlation coefficient between surface and needle measurements across the 12 subjects.  
Correlation was very high for the early components, but relatively weak for the later 
components of the recovery cycle.. 
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Discussion 
This study demonstrates that MVRCs with 1 and 2 conditioning stimuli, which previously 
have only been reported for recordings with concentric needle electrodes, can also be 
recorded with surface electrodes in healthy subjects.  The surface MAPs were smaller than 
those recorded with needles, but the MVRC measurements did not differ in any statistically 
significant respect between the 2 recording methods.    
Although the MVRC averages were similar for surface and needle recordings, it was 
noticeable that only the early parts of the recovery cycle (refractoriness and early 
supernormality) showed a very strong correlation between surface and needle measurements 
across the 12 subjects (Table 1).  Inter-subject differences in the later parts of the recovery 
cycle appear to be masked partly by the intrinsic variability of those measurements.  A similar 
finding was noted in an earlier study of the repeatability of MVRCs; the intraclass correlation 
coefficient between 2 MVRC recordings from the same subjects made a week apart was much 
higher for early than for late supernormality4.  We conclude that although the later parts of the 
recovery cycle can be useful to detect membrane abnormalities in groups of patients, such as 
XLSN in Andersen-Tawil syndrome10, they are likely to be of limited diagnostic value for 
individual patients. 
 
The method of measuring MVRCs was developed to investigate changes of muscle 
membrane properties independent of nerve function1,2. To achieve this goal a column of 
muscle fibers is stimulated via a monopolar needle electrode, and evoked MAPs are recorded 
with a concentric needle electrode. Positioning of the recording needle electrode can 
sometimes be difficult, since it must be positioned in the vicinity of the activated muscle 
fibers, particularly if these fibers are located in the depth of the muscle and are therefore not 
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palpable. Furthermore, this method suffers from a slight risk that the recording needle can be 
displaced as a consequence of the muscle fiber twitches. Hence, the use of surface electrodes 
could facilitate recordings. In this study, we positioned the active electrode on the skin 
overlying the tip of the concentric needle electrode between 2 reference electrodes. This 
tripolar electrode arrangement was used to get a well-defined maximal negative peak of the 
MAP for accurate latency measurements, and it enabled us to record MAPs of good quality in 
all subjects. We had expected that the surface recordings might be more stable, because the 
risk of movement of the concentric needle electrode was avoided, but in fact the variability of 
the peak MAPs during the recording period of 5-6 minutes was similar for the 2 methods 
(Table 1).  This implies that much of the variability with the conventional method arises from 
movement of the stimulating rather than the recording needle electrode. 
 
 
In this study only 12 healthy young volunteers were examined. The data show that MVRCs 
can be recorded in this population with surface as well as with needle electrodes, which may 
facilitate the recording procedure. However, it should be noted that we have not yet made any 
surface recordings in patients with muscle disease, and in some muscle pathologies MAPs are 
typically of reduced amplitude, which might make the smaller surface recordings more 
difficult because of a borderline signal-to-noise ratio. 
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Figure legends 
 
Figure 1:  Electrode arrangement for measurement of MVRCs.  Stimulation: A monopolar 
insulated needle electrode was inserted perpendicularly into the brachioradialis muscle at 
about 25% of the distance from the lateral epicondyle of the humerus to the styloid process of 
the radius. A surface electrode served as anode and was attached distal to the cathode. 
Recordings were made simultaneously with a concentric EMG electrode and surface 
electrodes. The concentric EMG electrode was inserted slightly oblique into the 
brachioradialis muscle about 20 to 25 mm proximal to the cathode.  The active surface 
electrode was placed on the skin above the tip of the concentric EMG electrode. Two surface 
anodes were placed adjacent proximal and distal to the cathode. 
 
Figure 2: Multi-fiber CMAP recorded from a subject with 1 conditioning stimulus. The left 
column shows the inter-stimulus intervals between the conditioning and test stimuli 
(logarithmic scale). The middle column shows CMAPs evoked by the test stimulus and 
recorded with surface electrodes, and the right column shows the CMAPs recorded with a 
needle electrode.  
 
Figure 3: Mean muscle velocity recovery cycles (MVRCs) recorded with surface electrodes 
(A) and needle electrodes (B). The dashed lines indicated the standard errors of the mean. The 
upper panel shows MVRCs recorded with 1 conditioning stimulus. The lower panels display 
the differences in latency between recordings with 1 and 2 conditioning stimuli. C) 
Superimposition of averaged surface and needle recordings. 
 
Figure 4: Individual comparisons of the most important MVRC parameters for both 
recording techniques. A) MRRP, B) Time to peak supernormality, C) ESN, and D) LSN. For 
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all parameters, no statistical differences were found between recordings with surface and 
needle electrodes.  
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Surface 
(mean ± SE) 
Needle 
(mean ± SE) 
Difference         
(mean ± SE) 
P 
(paired t-test) 
 
R 
Peak amplitude        
(mV) 
0.64 ± 0.15 1.50 ± 0.24 -0.86 ± 0.29 0.012* -0.038 
Peak variability 
(CV, %) 
7.7 ± 1.1 7.0 ± 1.7 0.7 ± 1.8 0.71 0.200 
Relative refractory 
period (ms) 
3.23 ± 0.13 3.24 ± 0.12 0.01 ± 0.02 0.70 0.983**** 
Time to peak 
supernormality (ms) 
6.91 ± 0.28  6.89 ± 0.30 -0.02 ± 0.11 0.81 0.935**** 
Early supernormality      
(< 15 ms, %) 
10.21 ± 0.79 10.19 ± 0.96 -0.02 ± 0.36 0.92 0.932**** 
Late supernormality   
(50-150 ms, %) 
4.16 ± 0.37 4.65 ± 0.44 0.49 ± 0.38 0.22 0.572 
Extra late supernormality 
(2-1 cond. Stim, %) 
2.84 ± 0.44 3.52 ± 0.56 0.69 ± 0.40 0.11 0.701* 
Residual supernormality 
(950 ms, %) 
0.30 ± 0.14 0.20 ± 0.17 -0.10 ± 0.11 0.42 0.742** 
 
Table 1   Comparison between MVRCs recorded simultaneously from the surface and from 
a concentric needle in 12 normal subjects.  Peak amplitudes are the submaximal peaks of 
the filtered multi-unit waveforms used for the MVRC measurements.  The peak variability 
is expressed as the coefficient of variation of the control peak amplitudes over the 5-6 
minutes of the recordings.  Only the peak amplitudes showed a significant difference 
between surface and needle recordings.  The last column shows the correlation coefficient 
between surface and needle measurements over the 12 subjects, with P values indicated 
by asterisks only (* = P<0.05, ** = P<0.01, **** = P<0.0001). 
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